Showing results (81-90 of 276) with videos related to
Sort By:
Pageof 28
Lung Cancer (Amsterdam, Netherlands)|March 19, 2013
A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutationsDoraid Alrifai, Sanjay Popat, Merina Ahmed, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2010
Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysisAndrew G Nicholson, David Gonzalez, Pallav Shah, et al.Journal of Comparative Effectiveness Research|January 11, 2024
Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchersKristian Thorlund, Stephen Duffield, Sanjay Popat, et al.Cancer Letters|October 22, 2003
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinomaLara Lipton, Christina Fleischmann, Oliver M Sieber, et al.Familial Cancer|December 8, 2009
Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patientIsmail Alrashdi, Samantha Levine, Joan Paterson, et al.BMC Cancer|April 27, 2013
Early pneumothorax as a feature of response to crizotinib therapy in a patient with ALK rearranged lung adenocarcinomaSpyridon Gennatas, Susana J Stanway, Robert Thomas, et al.Plos One|July 7, 2022
Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapyFrancesca Castagnoli, Simon Doran, Jason Lunn, et al.Diabetic Medicine : a Journal of the British Diabetic Association|January 25, 2023
Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessmentKaenat Mulla, Sheima Farag, Benedict Moore, et al.JTO Clinical and Research Reports|August 2, 2024
Successful Lorlatinib Rechallenge After Severe Drug-Induced Psychosis in ALK-Positive Metastatic NSCLC: A Case ReportAlexius John, Joanna Vick, Sarah Sarker, et al.Lung Cancer (Amsterdam, Netherlands)|December 13, 2006
Recurrent responses to non-small cell lung cancer brain metastases with erlotinibSanjay Popat, Sarah Hughes, Panos Papadopoulos, et al.Pageof 28